OBJECTIVES: The matrix protein hyaluronic acid (HA, hyaluronan) has possibly additional immune-regulatory functions in inflammation. We aimed at evaluating serum HA concentrations in critically ill patients. DESIGN AND METHODS: We analyzed serum HA levels in 164 critically ill patients at a medical ICU and 61 healthy controls, with respect to organ dysfunction, systemic inflammation and mortality. RESULTS: Hyaluronan serum concentrations upon admission to ICU were significantly elevated in critically ill patients compared to healthy controls, with the highest levels in patients with pre-existing liver cirrhosis or sepsis. HA levels were closely correlated with biomarkers of hepatic and renal function, systemic inflammation, demand of treatment measures and clinical scores of disease severity, but could not predict risk of mortality. CONCLUSIONS: Measurement of serum HA may supplement the assessment of disease severity in ICU patients. Our data suggest that HA might have implications in the pathogenesis of critical illness and sepsis.
OBJECTIVES: The matrix protein hyaluronic acid (HA, hyaluronan) has possibly additional immune-regulatory functions in inflammation. We aimed at evaluating serum HA concentrations in critically ill patients. DESIGN AND METHODS: We analyzed serum HA levels in 164 critically ill patients at a medical ICU and 61 healthy controls, with respect to organ dysfunction, systemic inflammation and mortality. RESULTS:Hyaluronan serum concentrations upon admission to ICU were significantly elevated in critically ill patients compared to healthy controls, with the highest levels in patients with pre-existing liver cirrhosis or sepsis. HA levels were closely correlated with biomarkers of hepatic and renal function, systemic inflammation, demand of treatment measures and clinical scores of disease severity, but could not predict risk of mortality. CONCLUSIONS: Measurement of serum HA may supplement the assessment of disease severity in ICU patients. Our data suggest that HA might have implications in the pathogenesis of critical illness and sepsis.
Authors: Eric P Schmidt; Guoyun Li; Lingyun Li; Li Fu; Yimu Yang; Katherine H Overdier; Ivor S Douglas; Robert J Linhardt Journal: J Biol Chem Date: 2014-02-07 Impact factor: 5.157
Authors: Bernhard F Becker; Matthias Jacob; Stephanie Leipert; Andrew H J Salmon; Daniel Chappell Journal: Br J Clin Pharmacol Date: 2015-05-22 Impact factor: 4.335
Authors: Jennifer E Rowley; Gillian E Rubenstein; Sharrόn L Manuel; Natalie L Johnson; Jordan Surgnier; Pinelopi P Kapitsinou; Francesca E Duncan; Michele T Pritchard Journal: J Histochem Cytochem Date: 2019-11-12 Impact factor: 2.479
Authors: Theis S Itenov; Nikolai S Kirkby; Morten H Bestle; Anna C Nilsson; Erland J Erlandsen; Lars Peters; Jens-Ulrik Jensen Journal: J Clin Lab Anal Date: 2015-12-14 Impact factor: 2.352